Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 90

1.

How I treat pancreatic ductal adenocarcinoma.

Tempero MA.

J Oncol Pract. 2008 Jan;4(1):46-7. doi: 10.1200/JOP.0818501. No abstract available.

2.

Overexpression of the Wilms' tumor gene WT1 in pancreatic ductal adenocarcinoma.

Oji Y, Nakamori S, Fujikawa M, Nakatsuka S, Yokota A, Tatsumi N, Abeno S, Ikeba A, Takashima S, Tsujie M, Yamamoto H, Sakon M, Nezu R, Kawano K, Nishida S, Ikegame K, Kawakami M, Tsuboi A, Oka Y, Yoshikawa K, Aozasa K, Monden M, Sugiyama H.

Cancer Sci. 2004 Jul;95(7):583-7.

3.

Use of MDCT to Differentiate Autoimmune Pancreatitis From Ductal Adenocarcinoma and Interstitial Pancreatitis.

Lee-Felker SA, Felker ER, Kadell B, Farrell J, Raman SS, Sayre J, Lu DS.

AJR Am J Roentgenol. 2015 Jul;205(1):2-9. doi: 10.2214/AJR.14.14059.

PMID:
26102377
4.

Unresectable pancreatic ductal adenocarcinoma in the remnant pancreas diagnosed during every-6-month surveillance after resection of branch duct intraductal papillary mucinous neoplasm: a case report.

Tamura K, Ohtsuka T, Ideno N, Aso T, Kono H, Nagayoshi Y, Shindo K, Ushijima Y, Ueda J, Takahata S, Ito T, Oda Y, Mizumoto K, Tanaka M.

JOP. 2013 Jul 10;14(4):450-3. doi: 10.6092/1590-8577/1494.

5.

Identification of novel predictive markers for the prognosis of pancreatic ductal adenocarcinoma.

Luo Y, Qiu Z, Tian L, Zhu G, Feng Y, Yi M, Chen X, Wang L, Li C, Huang Q.

Hum Pathol. 2013 Jan;44(1):69-76. doi: 10.1016/j.humpath.2012.04.014. Epub 2012 Aug 30.

PMID:
22939953
6.

Reevaluation and identification of the best immunohistochemical panel (pVHL, Maspin, S100P, IMP-3) for ductal adenocarcinoma of the pancreas.

Liu H, Shi J, Anandan V, Wang HL, Diehl D, Blansfield J, Gerhard G, Lin F.

Arch Pathol Lab Med. 2012 Jun;136(6):601-9. doi: 10.5858/arpa.2011-0326-OA.

PMID:
22646265
7.

Pancreatic ductal adenocarcinoma in hereditary diffuse gastric cancer. A case report.

Ottenhof NA, de Wilde RF, Morsink FH, de Leng WW, Ausems MG, Morreau H, van Hillegersberg R, Offerhaus GJ, Milne AN.

Hum Pathol. 2012 Mar;43(3):457-61. doi: 10.1016/j.humpath.2011.06.008. Epub 2011 Oct 10.

8.

Association of microRNA-21 expression with its targets, PDCD4 and TIMP3, in pancreatic ductal adenocarcinoma.

Nagao Y, Hisaoka M, Matsuyama A, Kanemitsu S, Hamada T, Fukuyama T, Nakano R, Uchiyama A, Kawamoto M, Yamaguchi K, Hashimoto H.

Mod Pathol. 2012 Jan;25(1):112-21. doi: 10.1038/modpathol.2011.142. Epub 2011 Oct 7.

10.

Clinical significance of cathepsin E in pancreatic juice in the diagnosis of pancreatic ductal adenocarcinoma.

Uno K, Azuma T, Nakajima M, Yasuda K, Hayakumo T, Mukai H, Sakai T, Kawai K.

J Gastroenterol Hepatol. 2000 Nov;15(11):1333-8.

PMID:
11129230
11.

GADD45alpha is highly expressed in pancreatic ductal adenocarcinoma cells and required for tumor cell viability.

Schneider G, Weber A, Zechner U, Oswald F, Friess HM, Schmid RM, Liptay S.

Int J Cancer. 2006 May 15;118(10):2405-11.

12.

Expression and diagnostic evaluation of the human tumor-associated antigen RCAS1 in pancreatic cancer.

Akashi T, Oimomi H, Nishiyama K, Nakashima M, Arita Y, Sumii T, Kimura T, Ito T, Nawata H, Watanabe T.

Pancreas. 2003 Jan;26(1):49-55.

PMID:
12499917
13.

Sialylated MUC1 mucin expression in normal pancreas, benign pancreatic lesions, and pancreatic ductal adenocarcinoma.

Masaki Y, Oka M, Ogura Y, Ueno T, Nishihara K, Tangoku A, Takahashi M, Yamamoto M, Irimura T.

Hepatogastroenterology. 1999 Jul-Aug;46(28):2240-5.

PMID:
10521973
14.
15.

HMGA1 correlates with advanced tumor grade and decreased survival in pancreatic ductal adenocarcinoma.

Hristov AC, Cope L, Di Cello F, Reyes MD, Singh M, Hillion JA, Belton A, Joseph B, Schuldenfrei A, Iacobuzio-Donahue CA, Maitra A, Resar LM.

Mod Pathol. 2010 Jan;23(1):98-104. doi: 10.1038/modpathol.2009.139. Epub 2009 Oct 9.

16.

Use of IHC and newly designed matriptase inhibitors to elucidate the role of matriptase in pancreatic ductal adenocarcinoma.

Uhland K, Siphos B, Arkona C, Schuster M, Petri B, Steinmetzer P, Mueller F, Schweinitz A, Steinmetzer T, Van De Locht A.

Int J Oncol. 2009 Aug;35(2):347-57.

PMID:
19578749
17.

Pancreaticoduodenectomy of pancreatic ductal adenocarcinoma in the elderly.

Kang CM, Kim JY, Choi GH, Kim KS, Choi JS, Lee WJ, Kim BR.

Yonsei Med J. 2007 Jun 30;48(3):488-94.

18.

Distribution of somatostatin in pancreatic ductal adenocarcinoma remodels the normal pattern of the protein during foetal pancreatic development: an immunohistochemical analysis.

Tamiolakis D, Simopoulos C, Venizelos J, Lambropoulou M, Nikolaidou S, Tsikouras P, Koutsougeras G, Alexiadis G, Menegaki M, Papadopoulos N.

Clin Exp Med. 2005 Oct;5(3):106-11.

PMID:
16284732
19.

Pancreatic-polypeptide in the human pancreas: expression and quantitative variation during development and in ductal adenocarcinoma.

Tamiolakis D, Simopoulos C, Kotini A, Venizelos I, Jivannakis T, Papadopoulos N.

Acta Medica (Hradec Kralove). 2003;46(1):9-14.

PMID:
12747533
20.

Pancreatic ductal adenocarcinoma associated with pancreatic ductal intraepithelial neoplasia: report of a case.

Krishnasamy R, Agarwal S, Singh S, Puri S, Sakhuja P, Agarwal AK.

Hepatobiliary Pancreat Dis Int. 2007 Oct;6(5):553-6.

PMID:
17897923

Supplemental Content

Support Center